1.Im WH，Song JS，Park EH，et al. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging：evaluation of patients with multiple MR examinations. Abdom Radiol（NY），2017，42（10）：2393-2401.

2.Davenport MS，Bashir MR，Pietryga JA，et al. Dose-toxicity relationship of gadoxetate disodium and transient severe respiratory motion artifact. AJR Am J Roentgenol，2014，203（4）：796-802.

3.Davenport MS，Malyarenko DI，Pang Y，et al. Effect of Gadoxetate Disodium on Arterial Phase Respiratory Waveforms Using a Quantitative Fast Fourier Transformation-Based Analysis. AJR Am J Roentgenol，2017，208（2）：328-336.

4.Haradome H，Grazioli L，Tsunoo M，et al. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA（Gd-EOB-DTPA）-enhanced hepatic MR imaging? J Magn Reson Imaging，2010，32（2）：334-340.

5.Kanki A，Tamada T，Abe T，et al. Relationship between transient severe motion of the liver in gadoxetic acid or iodinated contrast agent-enhanced imaging and arterial oxygen saturation and heart rate changes. Magn Reson Imaging，2018，53：77-81.

6.Kim SY，Park SH，Wu EH，et al. Transient respiratory motion artifact during arterial phase MRI with gadoxetate disodium：risk factor analyses. AJR Am J Roentgenol，2015，204（6）：1220-1227.

7.Li H，Xiao Y，Wang S，et al. TWIST-VIBE five-arterial-phase technology decreases transient severe motion after bolus injection of Gd-EOB-DTPA. Clin Radiol，2017，72（9）：800 e801-800 e806.

8.Namimoto T，Shimizu K，Nakagawa M，et al. Reducing artifacts of gadoxetate disodium-enhanced MRI with oxygen inhalation in patients with prior episode of arterial phase motion：intra-individual comparison. Clin Imaging，2018，52：11-15.

9.Polanec SH，Bickel H，Baltzer PAT，et al. Respiratory motion artifacts during arterial phase imaging with gadoxetic acid：Can the injection protocol minimize this drawback? J Magn Reson Imaging，2017，46（4）：1107-1114.

10.Ringe KI，von Falck C，Raatschen HJ，et al. Evaluation of transient respiratory motion artifact at gadoxetate disodiumenhanced MRI-Influence of different contrast agent application protocols. PLoS One，2018，13（7）：e0200887.

11.Song JS，Choi EJ，Park EH，et al. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI：effect of modified breath-holding method. Eur Radiol，2018，28（3）：1132-1139.

12.Xiao YD，Ma C，Liu J，et al. Transient severe motion during arterial phase in patients with Gadoxetic acid administration：Can a five hepatic arterial subphases technique mitigate the artifact? Exp Ther Med，2018，15（3）：3133-3139.

13.Bashir MR，Castelli P，Davenport MS，et al. Respiratory motion artifact affecting hepatic arterial phase MR imaging with gadoxetate disodium is more common in patients with a prior episode of arterial phase motion associated with gadoxetate disodium. Radiology，2015，274（1）：141-148.

14.Pietryga JA，Burke LM，Marin D，et al. Respiratory motion artifact affecting hepatic arterial phase imaging with gadoxetate disodium：examination recovery with a multiple arterial phase acquisition. Radiology，2014，271（2）：426-434.

15.Motosugi U，Bannas P，Bookwalter CA，et al. An Investigation of Transient Severe Motion Related to Gadoxetic Acidenhanced MR Imaging. Radiology，2016，279（1）：93-102.

16.McClellan TR，Motosugi U，Middleton MS，et al. Intravenous Gadoxetate Disodium Administration Reduces Breath-holding Capacity in the Hepatic Arterial Phase：A Multi-Center Randomized Placebo-controlled Trial. Radiology，2017，282（2）：361-368.

17.Davenport MS，Viglianti BL，Al-Hawary MM，et al. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine：effect on arterial phase image quality. Radiology，2013，266（2）：452-461.

18.Davenport MS，Caoili EM，Kaza RK，et al. Matched within-patient cohort study of transient arterial phase respiratory motionrelated artifact in MR imaging of the liver：gadoxetate disodium versus gadobenate dimeglumine. Radiology，2014，272（1）：123-131.

19.Denecke T，Steffen IG，Agarwal S，et al. Appearance of hepatocellular adenomas on gadoxetic acid-enhanced MRI. Eur Radiol，2012，22（8）：1769-1775.

20.Chung SH，Kim MJ，Choi JY，et al. Comparison of two different injection rates of gadoxetic acid for arterial phase MRI of the liver. J Magn Reson Imaging，2010，31（2）：365-372.

21.Rohrer M，Bauer H，Mintorovitch J，et al. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol，2005，40（11）：715-724.

22.Gruber L，Rainer V，Plaikner M，et al. CAIPIRINHA-Dixon-TWIST（CDT）-VIBE MR imaging of the liver at 3.0T with gadoxetate disodium：a solution for transient arterial-phase respiratory motion-related artifacts? Eur Radiol，2018，28（5）：2013-2021.

23.Qu J，Han S，Zhang H，et al. Arterial Phase with CAIPIRINHA-Dixon-TWIST（CDT）-Volume-Interpolated Breath-Hold Examination（VIBE）in Detecting Hepatic Metastases. Transl Oncol，2017，10（1）：46-53.

24.Qu J，Han S，Zhang H，et al. Improved Detection of Recurrent Hepatocellular Carcinomas in Arterial Phase With CAIPIRINHA-Dixon-TWIST-Volumetric Interpolated Breath-Hold Examination. Invest Radiol，2016，51（10）：602-608.

25.Kazmierczak PM，Theisen D，Thierfelder KM，et al. Improved detection of hypervascular liver lesions with CAIPIRINHADixon-TWIST-volume-interpolated breath-hold examination. Invest Radiol，2015，50（3）：153-160.

26.Chandarana H，Block TK，Ream J，et al. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.Invest Radiol，2015，50（2）：88-94.

27.Bashir MR，Merkle EM. Improved liver lesion conspicuity by increasing the flip angle during hepatocyte phase MR imaging.Eur Radiol，2011，21（2）：291-294.

28.Elsayes KM，Kielar AZ，Elmohr MM，et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol（NY），2018，43（10）：2625-2642.

29.Gomi T，Nagamoto M，Hasegawa M，et al. Radial MRI during free breathing in contrast-enhanced hepatobiliary phase imaging. Acta Radiol，2014，55（1）：3-7.

30.Cho ES，Yu JS，Park AY，et al. Feasibility of 5-minute delayed transition phase imaging with 30 degrees flip angle in gadoxetic acid-enhanced 3D gradient-echo MRI of liver，compared with 20-minute delayed hepatocyte phase MRI with standard 10 degrees flip angle. AJR Am J Roentgenol，2015，204（1）：69-75.

31.Cohen-Hallaleh V，Guo L，Hosseini-Nik H，et al. Does injection flow rate have an impact on arterial phase image degradation in liver MRI? A comparison of gadoxetic acid versus gadobutrol. Clin Radiol，2017，72（11）：994 e991-994 e998.

32.Liang M，Zhao J，Xie B，et al. MR liver imaging with Gd-EOB-DTPA：The need for different delay times of the hepatobiliary phase in patients with different liver function. Eur J Radiol，2016，85（3）：546-552.

33.Tamada T，Ito K，Yoshida K，et al. Comparison of three different injection methods for arterial phase of Gd-EOB-DTPA enhanced MR imaging of the liver. Eur J Radiol，2011，80（3）：e284-288.

34.Gutzeit A，Matoori S，Froehlich JM，et al. Reduction in respiratory motion artefacts on gadoxetate-enhanced MRI after training technicians to apply a simple and more patient-adapted breathing command. Eur Radiol，2016，26（8）：2714-2722.

35.Kim YC，Min JH，Kim YK，et al. Intra-individual comparison of gadolinium-enhanced MRI using pseudo-golden-angle radial acquisition with gadoxetic acid-enhanced MRI for diagnosis of HCCs using LI-RADS. Eur Radiol，2019，29（4）：2058-2068.

36.Song JS，Choi EJ，Park EH，et al. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI：effect of modified breath-holding method. Eur Radiol，2018，28（3）：1132-1139.

37.Weiss J，Taron J，Othman AE，et al. Feasibility of self-gated isotropic radial late-phase MR imaging of the liver. Eur Radiol，2017，27（3）：985-994.

38.Chandarana H，Block TK，Ream J，et al. Estimating liver perfusion from free-breathing continuously acquired dynamic gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced acquisition with compressed sensing reconstruction.Invest Radiol，2015，50（2）：88-94.

39.Chandarana H，Feng L，Ream J，et al. Respiratory Motion-Resolved Compressed Sensing Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic Resonance Imaging. Invest Radiol，2015，50（11）：749-756.

40.Kim J，Kim BS，Lee JS，et al. Optimization of the Flip Angle and Scan Timing in Hepatobiliary Phase Imaging Using T1-Weighted，CAIPIRINHA GRE Imaging. Investigative Magnetic Resonance Imaging，2018，22（1）：1.

41.Iyama Y，Nakaura T，Yokoyama K，et al. Comparison of the Timing of Hepatic Arterial Phase and Image Quality Using Test-Bolus and Bolus-Tracking Techniques in Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced Hepatic Dynamic Magnetic Resonance Imaging. J Comput Assist Tomogr，2017，41（4）：638-643.

42.Haradome H，Grazioli L，Al manea K，et al. Gadoxetic acid disodium-enhanced hepatocyte phase MRI：can increasing the flip angle improve focal liver lesion detection? J Magn Reson Imaging，2012，35（1）：132-139.

43.Haradome H，Grazioli L，Tsunoo M，et al. Can MR fluoroscopic triggering technique and slow rate injection provide appropriate arterial phase images with reducing artifacts on gadoxetic acid-DTPA（Gd-EOB-DTPA）-enhanced hepatic MR imaging? J Magn Reson Imaging，2010，32（2）：334-340.

44.Huh J，Kim SY，Yeh BM，et al. Troubleshooting Arterial-Phase MR Images of Gadoxetate Disodium-Enhanced Liver. Korean J Radiol，2015，16（6）：1207-1215.

45.Li RK，Palmer SL，Zeng MS，et al. Detection of Endogenous Iron Reduction during Hepatocarcinogenesis at Susceptibility-Weighted MR Imaging：Value for Characterization of Hepatocellular Carcinoma and Dysplastic Nodule in Cirrhotic Liver.PLoS One，2015，10（11）：e0142882.

46.Cieszanowski A，Podgorska J，Rosiak G，et al. Gd-EOB-DTPA-Enhanced MR Imaging of the Liver：The Effect on T2 Relaxation Times and Apparent Diffusion Coefficient（ADC）．Pol J Radiol，2016，81：103-109.

47.Guglielmo FF，Mitchell DG，Gupta S. Gadolinium contrast agent selection and optimal use for body MR imaging. Radiol Clin North Am，2014，52（4）：637-656.

48.ChandaranaH，Block TK，Ream J，et al. Estimating LiverPerfusion From Free-breathing Continuously Acquired Dynamic Gd-EOB-DTPAEnhanced Acquisition With Compressed Sensing Reconstruction. Invest Radiol，2015，50（2）：88-94.

49.Riffel P，Zoellner FG，Budjan J，et al. One-Stop Shop：Free-Breathing Dynamic Contrast-EnhancedMagnetic Resonance Imaging of the Kidney Using Iterative Reconstruction andContinuous Golden-Angle Radial Sampling. Invest Radiol，2016，（10）：1097.

50.RosenkrantzA B，Geppert C，Grimm R，et al. Dynamic contrast-enhanced MRI of the prostate with highspatiotemporal resolution using compressed sensing，parallel imaging，andcontinuous golden-angle radial sampling：Preliminary experience.Journal of MagneticResonance Imaging，2015，41（5）：1365-1373.

51.Kim YK，Lin WC，Sung K，et al. Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging：Dilution Method versus Reduced Injection Rate. Radiology，2017，283（2）：429-437.

52.杨正汉，冯逢，王霄英．磁共振成像技术指南．北京：人民卫生出版社，2010.

53.马文婷，黎金葵，翟亚楠，等．CAIPIRINHA-Dixon-TWIST-VIBE技术诊断小肝癌的研究进展．中国医学影像技术，2017，33（08）：1277-1280.

54.韩玉娟，于长路，贾科峰，等．不同注射流率及动脉期期相选择对肝脏普美显增强MRI图像质量的影响．临床放射学杂志，2016，35（01）：138-142.